RxDoctor Payments Data

Kelly Herring

Nurse Practitioner · Anderson, SCNPI 1801360748

Payments from drug & device makers

$4,321in general payments, 2019–2025

Across 157 payments — averaging $27.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • AstraZeneca$566
  • Novo Nordisk$266
  • Mallinckrodt Hospital Products Inc.$244
  • Calliditas Therapeutics US Inc.$216
  • Akebia Therapeutics Inc$212
  • plus $2K from 21 others

What the payments were for

  • Travel & lodging$1,11626%
  • Food & beverage$3,05571%
  • Education$1493%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,321 in reported general payments places this provider in the 90th percentile of 1,346 nurse practitioner providers in South Carolina.

See all nurse practitioner providers in South Carolina

Medicare billing

Part B allowed, 2024
$25,455
Medicare patients
154
Services billed
326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol94$74,401
VeltassaPatiromer Calcium Sorbitex38$32,911
JardianceEmpagliflozin36$21,581
Sevelamer Carbonate22$2,583
Nifedipine ErNifedipine80$2,151
Calcium Acetate23$1,999
Hydralazine Hcl84$985
Calcitriol69$908
Losartan Potassium72$814
Amlodipine Besylate106$557
Minoxidil19$431
Lidocaine-PrilocaineLidocaine/Prilocaine17$362
Clonidine Hcl20$361
Carvedilol58$294
Valsartan17$235

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$566$74,40194 claims
Boehringer IngelheimJardiance$78$21,58136 claims
ANI Pharmaceuticals, Inc.Valsartan$30$23517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,346 nurse practitioner providers in South Carolina.

Other nurse practitioner in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →